- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 27.66M sh |
| Long Term Debt | Q1 2025 · Mar 28, 2025 | $17.76M |
| Long Term Debt | Q1 2025 · Dec 27, 2024 | $12.73M |
| Cash And Equivalents | Q1 2025 · Mar 28, 2025 | $9.18M |
| Cash And Equivalents | Q1 2025 · Dec 27, 2024 | $16.37M |
| Current Liabilities | Q1 2025 · Mar 28, 2025 | $47.19M |
| Current Liabilities | Q1 2025 · Dec 27, 2024 | $53.13M |
| Total Liabilities | Q1 2025 · Mar 28, 2025 | $77.35M |
| Total Liabilities | Q1 2025 · Dec 27, 2024 | $76.3M |
| Current Assets | Q1 2025 · Mar 28, 2025 | $75M |
| Current Assets | Q1 2025 · Dec 27, 2024 | $76.35M |
| Total Assets | Q1 2025 · Mar 28, 2025 | $191.76M |
| Total Assets | Q1 2025 · Dec 27, 2024 | $191.88M |
| Shares Diluted | Q1 2025 · Mar 29, 2024 | 27.68M sh |
| Stock Repurchased | Q1 2025 · Mar 29, 2024 | $1.06M |
| Capex | Q1 2025 · Mar 29, 2024 | $948K |
| Operating Cash Flow | Q1 2025 · Mar 29, 2024 | $2.79M |
| Stockholders Equity | Q1 2025 · Mar 29, 2024 | $93.48M |
| Stockholders Equity | Q1 2025 · Dec 29, 2023 | $90.08M |
| Eps Diluted | Q1 2025 · Mar 29, 2024 | $0.32 |
| Eps Basic | Q1 2025 · Mar 29, 2024 | $0.32 |
| Sga Expense | Q1 2025 · Mar 29, 2024 | $18.33M |
| Net Income | Q1 2025 · Mar 29, 2024 | $8.73M |
| Operating Income | Q1 2025 · Mar 29, 2024 | $11.53M |
| Revenue | Q1 2025 · Mar 29, 2024 | $77.19M |